Cargando…
Metformin suppressed the proliferation of LoVo cells and induced a time-dependent metabolic and transcriptional alteration
Metformin is a widely used anti-diabetic drug with potential anti-tumor activity. However, little is known about its global metabolic and transcriptional impacts on tumor cells. In current study, we performed a metabolic profiling on human-derived colon cancer LoVo cells treated by 10 mM metformin f...
Autores principales: | He, Jiaojiao, Wang, Ke, Zheng, Ningning, Qiu, Yunping, Xie, Guoxiang, Su, Mingming, Jia, Wei, Li, Houkai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663508/ https://www.ncbi.nlm.nih.gov/pubmed/26616174 http://dx.doi.org/10.1038/srep17423 |
Ejemplares similares
-
Effects of ADMA on gene expression and metabolism in serum-starved LoVo cells
por: Zheng, Ningning, et al.
Publicado: (2016) -
Laminarin-induced apoptosis in human colon cancer LoVo cells
por: JI, CHEN-FENG, et al.
Publicado: (2014) -
Magnesium homeostasis in colon carcinoma LoVo cells sensitive or resistant to doxorubicin
por: Castiglioni, Sara, et al.
Publicado: (2015) -
N-Hydroxyphthalimide exhibits antitumor activity by suppressing mTOR signaling pathway in BT-20 and LoVo cells
por: Wang, Min, et al.
Publicado: (2016) -
Gene Expression Profile of the Human Colorectal Carcinoma LoVo Cells Treated With Sporamin and Thapsigargin
por: Yang, Chun, et al.
Publicado: (2021)